14 results
8-K
EX-3.1
FATE
Fate Therapeutics Inc
10 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
EX-3.1
FATE
Fate Therapeutics Inc
19 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
EX-3.1
FATE
Fate Therapeutics Inc
7 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:50pm
10-K
2020 FY
EX-3.3
FATE
Fate Therapeutics Inc
Annual report
24 Feb 21
12:00am
8-K
EX-3.1
FATE
Fate Therapeutics Inc
22 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-3.1
u6hrer6k
19 Aug 20
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
4:01pm
8-K
EX-3.1
q5pmk
29 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1/A
EX-3.2
9aqe6na pqz
29 Aug 13
IPO registration (amended)
12:00am
S-1/A
EX-3.4
7t9qubz9
29 Aug 13
IPO registration (amended)
12:00am
S-1
EX-3.3
6ajt58jk
14 Aug 13
IPO registration
12:00am
S-1
EX-3.1
9t6mx 1lo1y
14 Aug 13
IPO registration
12:00am
DRS
EX-3
mam37 36oz5586j4b
20 Jun 13
Draft registration statement
12:00am
DRS
EX-3
cgr8b1lhz hkrsj94hmb
20 Jun 13
Draft registration statement
12:00am
- Prev
- 1
- Next